DUBLIN, July 26, 2022 /PRNewswire/ – The Clinical Decision Support Systems (CDSS) Market by Component (Services, Software), Delivery (On Premises, Cloud), Product (Standalone, Integrated), Application (Advanced, Therapeutic, Diagnostic), Interactivity (Active , passive) – Global Forecasts to 2027” Report has been added to ResearchAndMarkets.com offering.
The global market for clinical decision support systems (CDSS) is projected to reach $2.2 billion by 2027 from $1.5 billion in 2022, at a CAGR of 7.9% over the forecast period.
Sponsored Content:
The software segment is expected to grow at the highest rate during the forecast period
Based on the component, the CDSS market is segmented into: services, software, and hardware. In 2021, the service segment accounted for the majority of this market. Growth in this segment is attributed to the recurring nature of services such as training and development, installation, consulting and maintenance.
The on-premises solutions segment is estimated to account for the largest share of the clinical decision support systems market in 2022
Depending on the mode of delivery, clinical decision support systems are delivered to end users through on-premises and cloud-based modes. On-premises mode of delivery accounted for the largest share of the clinical decision support systems market in 2021. On the other hand, cloud-based mode of delivery is estimated to grow at the highest CAGR due to lower capital expenditures and operating costs. costs incurred in this model, along with its scalability, flexibility and affordability.
The integrated CDSS segment accounted for the majority of the global market for clinical decision support systems
Based on the product, the CDSS market is segmented into integrated CDSS and standalone CDSS. In 2021, the integrated CDSS segment accounted for the largest share of the market. Much of this segment can be attributed to the growing adoption of integrated CDSS in healthcare settings and organizations.
Therapeutic CDSS segment is expected to grow with the highest CAGR during the forecast period
Sponsored Content: OurLifeStore.com is a veteran-owned e-commerce with over 40,000 items at great prices and always free shipping
Based on type, the clinical decision support systems market is segmented into therapeutic CDSS and diagnostic CDSS. Therapeutic CDSS segment dominated this market in 2021. This segment is estimated to grow at a higher CAGR during the forecast period. The large share and high growth rate of this segment can be attributed to factors such as clinicians preferring therapeutic CDSS over diagnostic CDSS as it is more compatible with clinical workflows.
The knowledge-based CDSS segment accounted for the majority of the global market for clinical decision support systems
Based on the model, the CDSS market is segmented into knowledge-based CDSS and non-knowledge-based CDSS. In 2021, the knowledge-based CDSS segment accounted for the largest share of the market. This segment is also estimated to post the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the various benefits of these systems, such as helping clinicians with knowledge-based reasoning and making clinical decisions in uncertain situations. These systems can also be integrated into clinical workflows and are less prone to errors.
Active CDSS segment is expected to grow with the highest CAGR during the forecast period
Based on the level of interactivity, the CDSS market can be segmented into active CDSS and passive CDSS. Active CDSS segment accounted for the largest share of the market in 2021 and is anticipated to grow at the highest CAGR during the forecast period.
market dynamics
drivers
- Implementation of government regulations and initiatives to promote the adoption of HCIT solutions
- Increased adoption of CDS-enabled EHRs
- Growing collaborations and partnerships between stakeholders
- Increasing incidence of medication errors
- Development of Big Data and mHealth Tools
restrictions
- Data security concerns related to cloud-based CDS
- Inadequate interoperability
Opportunities
- Growth potential of emerging markets
- Integration of social networks and growing technological advances
challenges
- High Investment Requirement for CDS Infrastructure Implementation
- Shortage of qualified IT professionals in the healthcare industry
Key Topics Covered:
1. Introduction
2 Research Methodology
3 Executive summary
4 premium perspectives
5 Market Overview
6 Clinical Decision Support Systems Market, by Component
7 Clinical Decision Support Systems Market, by Product
8 Clinical Decision Support Systems Market, by Type
9 Clinical Decision Support Systems Market, by Model
10 Clinical Decision Support Systems Market, by Mode of Delivery
11 Clinical Decision Support Systems Market, by Application
12 Market for Clinical Decision Support Systems, by Level of Interactivity
13 Clinical Decision Support Systems Market, By Environment
14 Clinical Decision Support Systems Market, By Region
15 Competitive Landscape
16 company profiles
17 Appendix
Companies mentioned
- Healthcare Solutions from Allscripts, Inc.
- atenasalud
- Carecloud
- Cerner Corporation
- Change medical care
- Curemd
- Ebsco Health (a division of Ebsco Industries, Inc.)
- Eclinicalworks
- Elsevier B.V. (a division of the Relx Group)
- Epic Systems Corporation
- First database
- GE health
- Hera-Mi
- IBM Watson Health
- Meditech
- Next generation health care
- Philips Healthcare (a subsidiary of actual philips)
- medical ramp
- Siemens Healthineers
- Health Stanson
- Strata Decision Technology
- The Medical Algorithms Company
- visualdx
- Wolters Kluwer N.V..
- Health Zynx
For more information on this report, visit https://www.researchandmarkets.com/r/czlywy
Media Contact:
Research and Markets
laura woodSenior manager
[email protected]
Forest Office Hours Call +1-917-300-0470
For US/Canada call toll free +1-800-526-8630
for GMT Office Hours Call +353-1-416-8900
US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
